Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Manu

Showing results (31-40 of 93) with videos related to

Pageof 10
Sort By:
American Journal of Therapeutics|September 23, 2008
Antipsychotic-induced hyponatremia: case report and literature reviewIzchak Kohen, Suzanne Voelker, Peter Manu
CNS Spectrums|August 2, 2007
Serotonin syndrome in elderly patients treated for psychotic depression with atypical antipsychotics and antidepressants: two case reportsIzchak Kohen, Marc L Gordon, Peter Manu
American Journal of Therapeutics|July 6, 2021
Pharmacological Management of Diabetes Mellitus: A Century of Expert Opinions in Cecil Textbook of MedicinePeter Manu, Liliana M Rogozea, Simona Cernea
American Journal of Therapeutics|February 16, 2022
Pharmacological Management of Heroin Withdrawal Syndrome: A Century of Expert Opinions in Cecil Textbook of MedicinePeter Manu, Liliana M Rogozea, Matisyahu Shulman
American Journal of Therapeutics|March 6, 2018
Clozapine Rechallenge After Major Adverse Effects: Clinical Guidelines Based on 259 CasesPeter Manu, Yevgeniya Lapitskaya, Atef Shaikh, et al.
American Journal of Therapeutics|September 1, 2022
Pharmacological Management of Inflammatory Bowel Disease: a Century of Expert Opinions in Cecil Textbook of MedicinePeter Manu, Liliana M Rogozea, Dan L Dumitraşcu
American Journal of Therapeutics|July 10, 2018
Clozapine-Associated Pulmonary Embolism: A High-Mortality, Dose-Independent and Early-Onset Adverse EffectNilofar Sarvaiya, Yevgeniya Lapitskaya, Lorena Dima, et al.
American Journal of Therapeutics|November 10, 2021
Pharmacological Management of Myasthenia Gravis: A Century of Expert Opinions in Cecil Textbook of MedicinePeter Manu, Liliana M Rogozea, Corina Roman-Filip
The Journal of Clinical Psychiatry|March 29, 2008
Identification of high-risk coronary heart disease patients receiving atypical antipsychotics: single low-density lipoprotein cholesterol threshold or complex national standard?Christoph U Correll, John M Kane, Peter Manu
European Archives of Psychiatry and Clinical Neuroscience|December 15, 2010
Obesity and coronary risk in patients treated with second-generation antipsychoticsChristoph U Correll, John M Kane, Peter Manu
Pageof 10

Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
American Journal of Therapeutics|September 23, 2008
Antipsychotic-induced hyponatremia: case report and literature reviewIzchak Kohen, Suzanne Voelker, Peter Manu
CNS Spectrums|August 2, 2007
Serotonin syndrome in elderly patients treated for psychotic depression with atypical antipsychotics and antidepressants: two case reportsIzchak Kohen, Marc L Gordon, Peter Manu
American Journal of Therapeutics|July 6, 2021
Pharmacological Management of Diabetes Mellitus: A Century of Expert Opinions in Cecil Textbook of MedicinePeter Manu, Liliana M Rogozea, Simona Cernea
American Journal of Therapeutics|February 16, 2022
Pharmacological Management of Heroin Withdrawal Syndrome: A Century of Expert Opinions in Cecil Textbook of MedicinePeter Manu, Liliana M Rogozea, Matisyahu Shulman
American Journal of Therapeutics|March 6, 2018
Clozapine Rechallenge After Major Adverse Effects: Clinical Guidelines Based on 259 CasesPeter Manu, Yevgeniya Lapitskaya, Atef Shaikh, et al.
American Journal of Therapeutics|September 1, 2022
Pharmacological Management of Inflammatory Bowel Disease: a Century of Expert Opinions in Cecil Textbook of MedicinePeter Manu, Liliana M Rogozea, Dan L Dumitraşcu
American Journal of Therapeutics|July 10, 2018
Clozapine-Associated Pulmonary Embolism: A High-Mortality, Dose-Independent and Early-Onset Adverse EffectNilofar Sarvaiya, Yevgeniya Lapitskaya, Lorena Dima, et al.
American Journal of Therapeutics|November 10, 2021
Pharmacological Management of Myasthenia Gravis: A Century of Expert Opinions in Cecil Textbook of MedicinePeter Manu, Liliana M Rogozea, Corina Roman-Filip
The Journal of Clinical Psychiatry|March 29, 2008
Identification of high-risk coronary heart disease patients receiving atypical antipsychotics: single low-density lipoprotein cholesterol threshold or complex national standard?Christoph U Correll, John M Kane, Peter Manu
European Archives of Psychiatry and Clinical Neuroscience|December 15, 2010
Obesity and coronary risk in patients treated with second-generation antipsychoticsChristoph U Correll, John M Kane, Peter Manu
Pageof 10